1513 fundamentals
An in-depth look to LIVZON PHARMACEUTICAL GROUP INC operating, investing, and financing activities
1513 free cash flow for Q1 24 is 842.58 M HKD. For 2023, 1513 free cash flow was 2.84 B HKD and operating cash flow was 3.75 B HKD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM